TR199700392A2 - Kronik-fibrogenetik karaci�er hastal�klar�n�n, akut karaci�er hastal�klar�n�n ve bunlara ba�l� komplikasyonlar�n tedavi edilmesi ve �nlenmesi i�in peptik olmayan bradikinin antagonistlerinin kullan�lmas�. - Google Patents

Kronik-fibrogenetik karaci�er hastal�klar�n�n, akut karaci�er hastal�klar�n�n ve bunlara ba�l� komplikasyonlar�n tedavi edilmesi ve �nlenmesi i�in peptik olmayan bradikinin antagonistlerinin kullan�lmas�.

Info

Publication number
TR199700392A2
TR199700392A2 TR97/00392A TR9700392A TR199700392A2 TR 199700392 A2 TR199700392 A2 TR 199700392A2 TR 97/00392 A TR97/00392 A TR 97/00392A TR 9700392 A TR9700392 A TR 9700392A TR 199700392 A2 TR199700392 A2 TR 199700392A2
Authority
TR
Turkey
Prior art keywords
liver diseases
peptic
prevention
treatment
chronic
Prior art date
Application number
TR97/00392A
Other languages
English (en)
Turkish (tr)
Inventor
Holger Heitsch Dr.
Adalbert Wagner Dr.
Klaus Wirth Dr.
Max Hropot Dr.
Martin Bickel Dr.
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996120509 external-priority patent/DE19620509A1/de
Priority claimed from DE19632042A external-priority patent/DE19632042A1/de
Priority claimed from DE19639303A external-priority patent/DE19639303A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of TR199700392A2 publication Critical patent/TR199700392A2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR97/00392A 1996-05-22 1997-05-20 Kronik-fibrogenetik karaci�er hastal�klar�n�n, akut karaci�er hastal�klar�n�n ve bunlara ba�l� komplikasyonlar�n tedavi edilmesi ve �nlenmesi i�in peptik olmayan bradikinin antagonistlerinin kullan�lmas�. TR199700392A2 (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE1996120509 DE19620509A1 (de) 1996-05-22 1996-05-22 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19632042A DE19632042A1 (de) 1996-08-08 1996-08-08 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19639303A DE19639303A1 (de) 1996-09-25 1996-09-25 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US08/858,550 US5786365A (en) 1996-05-22 1997-05-19 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Publications (1)

Publication Number Publication Date
TR199700392A2 true TR199700392A2 (xx) 1997-12-21

Family

ID=27438369

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00392A TR199700392A2 (xx) 1996-05-22 1997-05-20 Kronik-fibrogenetik karaci�er hastal�klar�n�n, akut karaci�er hastal�klar�n�n ve bunlara ba�l� komplikasyonlar�n tedavi edilmesi ve �nlenmesi i�in peptik olmayan bradikinin antagonistlerinin kullan�lmas�.

Country Status (23)

Country Link
US (1) US5786365A (https=)
EP (2) EP0808627A2 (https=)
JP (1) JP4034849B2 (https=)
CN (1) CN1176102A (https=)
AT (1) ATE189389T1 (https=)
AU (1) AU2351197A (https=)
BR (1) BR9703367A (https=)
CA (1) CA2205780A1 (https=)
CZ (1) CZ154697A3 (https=)
DE (1) DE59701078D1 (https=)
DK (1) DK0808628T3 (https=)
ES (1) ES2144291T3 (https=)
GR (1) GR3033048T3 (https=)
HR (1) HRP970278A2 (https=)
HU (1) HUP9700913A1 (https=)
ID (1) ID18447A (https=)
IL (1) IL120862A0 (https=)
NO (1) NO972311L (https=)
PL (1) PL320134A1 (https=)
PT (1) PT808628E (https=)
SI (1) SI0808628T1 (https=)
SK (1) SK63097A3 (https=)
TR (1) TR199700392A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
US6767889B1 (en) 1998-11-10 2004-07-27 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
EP1044012B1 (en) 1998-11-10 2006-05-03 Temple University of the Commonwealth System of Higher Education Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
AU773862B2 (en) * 1998-11-10 2004-06-10 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
US6869931B1 (en) 1998-12-16 2005-03-22 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
US6994852B1 (en) 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6445588B1 (en) 2001-01-02 2002-09-03 Motorola, Inc. Apparatus and method for securing a printed circuit board to a base plate
RU2006124843A (ru) 2003-12-12 2008-01-20 Уайт (Us) Хинолины, пригодные для лечения сердечно-сосудистого заболевания
AU2006228957A1 (en) * 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
WO2012006103A2 (en) 2010-06-29 2012-01-12 Jennifer Digrazia Wound and bandage protection system and method
US12427067B2 (en) 2010-06-29 2025-09-30 Jennifer DiGrazia Wound and bandage protection system and method
US10517765B2 (en) 2010-06-29 2019-12-31 Jennifer DiGrazia Wound and bandage protection system and method
RU2514345C1 (ru) * 2012-10-09 2014-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования степени риска геморрагических осложнений при миниинвазивных хирургических вмешательствах на печени

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) * 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
WO1996004251A1 (en) * 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compound

Also Published As

Publication number Publication date
ID18447A (id) 1998-04-09
HU9700913D0 (en) 1997-07-28
MX9703725A (es) 1997-11-29
SI0808628T1 (en) 2000-04-30
AU2351197A (en) 1997-11-27
HUP9700913A1 (hu) 1999-09-28
CA2205780A1 (en) 1997-11-22
SK63097A3 (en) 1997-12-10
US5786365A (en) 1998-07-28
NO972311D0 (no) 1997-05-21
ATE189389T1 (de) 2000-02-15
EP0808628A2 (de) 1997-11-26
JP4034849B2 (ja) 2008-01-16
IL120862A0 (en) 1997-09-30
PL320134A1 (en) 1997-11-24
DK0808628T3 (da) 2000-06-26
CN1176102A (zh) 1998-03-18
DE59701078D1 (de) 2000-03-09
EP0808627A2 (de) 1997-11-26
GR3033048T3 (en) 2000-08-31
CZ154697A3 (en) 1997-12-17
HRP970278A2 (en) 1998-04-30
EP0808628B1 (de) 2000-02-02
BR9703367A (pt) 1998-09-15
NO972311L (no) 1997-11-24
PT808628E (pt) 2000-05-31
EP0808628A3 (de) 1998-01-14
JPH1045624A (ja) 1998-02-17
ES2144291T3 (es) 2000-06-01

Similar Documents

Publication Publication Date Title
TR199700392A2 (xx) Kronik-fibrogenetik karaci�er hastal�klar�n�n, akut karaci�er hastal�klar�n�n ve bunlara ba�l� komplikasyonlar�n tedavi edilmesi ve �nlenmesi i�in peptik olmayan bradikinin antagonistlerinin kullan�lmas�.
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
DE69523910D1 (de) Schieberegister mit gleich polarisierten mis-transistoren
PT1042305E (pt) Inibicao de quinase p38 utilizando difenilureias simetricas e assimetricas
IT1285345B1 (it) Forma di dosaggio comprendente ossibutinina
DE69625926D1 (de) Absorbierende zusammensetzung und saugfähiges wegwerfkleidungsstück, welches dasselbe enthält
IT232026Y1 (it) Corpo di doccia
FI974618A7 (fi) Kahden- ja kolmenarvoiset pienimolekyyliset selektiininestäjät
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
EE03420B1 (et) Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
DE60034879T8 (de) Lantibiotikum
NO982727D0 (no) PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon
BR0012675A (pt) Uso de inibidores de il-18
FI960850A7 (fi) Kinoksaliinien käyttö proteaasi-inhibiittoreihin yhdistettyinä lääkkeeksi AIDS:in ja/tai HIV-tartuntojen hoitamiseksi
DE69009196D1 (de) EEPROM, dessen Löschgate-Elektrodenmuster, die Muster des Source-Bereiches kreuzen und Verfahren zur Herstellung desselben.
FI941692L (fi) Naula paisunta-alueella
DK0797997T3 (da) Anvendelse af peptidiske bradykinin-antagonister til fremstilling af lægemidler
FI925782A7 (fi) Bradykinin-antagonisteja akuutin haimatulehduksen hoitamiseksi
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
PT1152768E (pt) Tratamento de infeccoes virais cronicas com m. vaccae
ATE136469T1 (de) Neue verwendung eines monoklonalen antikörpers
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
TR199801800T2 (xx) Uykusuzluk tedavisi.
KR970039602U (ko) 신원 확인이 가능한 열쇠